Monsanto can still swallow Bayer for $ 66 billion

facilitated time the industry has fallen in recent months after several multibillion-dollar mergers and acquisitions in motion. This also makes it the largest acquisition in the more than 150-year history of Bayer since the purchase of the pharmaceutical company Schering for 17 billion The two companies signed on Wednesday a binding merger agreement, as they communicated in a joint statement. The antitrust authorities must still approve. Bayer CEO Baumann had emphasized, however, the benefits of a merger. "This step will significantly strengthen the position of Bayer as a leading life science companies in the world." US stocks could easily stabilize after their recent losses, the recovery was slowed but the uncertainties ahead of the upcoming next week interest rate decision by the US Federal Reserve. Even Greenpeace spoke of a "bad news for sustainable farmers, consumers and the environment" and of an "unprecedented market power" for the company. The overall rating of Monsanto is 66 billion dollars (64 billion Fr.). Bayer had its range increased above again. The Monsanto deal, making it the largest takeover by a German group abroad and makes Bayer the world's number one in business with agricultural chemicals. Baumann has secured a credit line of 70 billion euros. "Because the competition authorities will look at the business accurately and then the rumored 2-billion default premium Bayer could still play an important role". Should the acquisition succeed, the experts had to Leverkusen therefore advised in advance to take advantage of their own, more positive image and delete the Monsanto brand as soon as possible. The Leverkusen-based company Monsanto rated as 66 billion dollars. Bayer had announced in May, to take over the controversial biotechnology giants. Based on a closing price of Monsanto shares on May 9, 2016 the day before the first written offer from Bayer, which is a premium of 44 percent to the former price. However, Monsanto is because of its aggressive practices and its genetically modified products in the criticism. The company also sells the weedkiller glyphosate, which is suspected to be carcinogenic. Green Party leader Anton Hofreiter demanded: "This deal may not give it." "He is instrumental in the decision, which come seeds and the pesticides on the market". For Bayer and Monsanto are not alone with their merger plans. The, launched in December amalgamation of Dupont and Dow Chemical also provides an industry giant.